Last update 19 Nov 2026

Crinecerfont

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Crinecerfont Hydrochloride, NBI-74788, SSR 125543A
+ [3]
Target
Action
antagonists
Mechanism
CRHR1 antagonists(Corticotropin-releasing factor receptor 1 antagonists)
Inactive Indication
Originator Organization
Active Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (13 Dec 2024),
RegulationPriority Review (United States), Breakthrough Therapy (United States), Fast Track (United States), Orphan Drug (United States), Orphan Drug (European Union), Rare Pediatric Disease (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC27H29Cl2FN2OS
InChIKeyBMXALUHUEGRRCH-JIDHJSLPSA-N
CAS Registry321839-75-2

External Link

KEGGWikiATCDrug Bank
D12366---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Classic Congenital Adrenal Hyperplasia
United States
13 Dec 2024
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 3
United States
16 Dec 2020
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 3
Austria
16 Dec 2020
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 3
Belgium
16 Dec 2020
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 3
Bulgaria
16 Dec 2020
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 3
Canada
16 Dec 2020
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 3
Czechia
16 Dec 2020
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 3
France
16 Dec 2020
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 3
Germany
16 Dec 2020
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 3
Greece
16 Dec 2020
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 3
Israel
16 Dec 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
182
dacvkhgptj(vnrsqlpdwi) = xfqiwbofkp twgfmdgpdf (ntmekvbpwl )
Positive
14 Jun 2026
Phase 3
182
cyehlhpxhw(vxonsrgjdw) = tdqkhgwzws jaqjkwhtrz (euimfipxjt, 1.6)
Positive
14 Jun 2026
Phase 3
182
zjafzqrzit(xvhokttley) = glwhxowfpc icfsjhjbzq (etqaxqsolm, 0.0 - 0.06)
Positive
14 Jun 2026
Phase 3
93
vewznqkuia(ienlgrprij) = svcoymadex izmrnzswjd (ythrklyvla )
Positive
14 Jun 2026
Phase 3
47
zzajpsjild(cozdnsmxka) = stymegdrmo ykietfldhb (onywoxooyl )
Positive
14 Jun 2026
Phase 3
87
bicjglzanh(ifqfyjcgct) = lfkkbzbedp mtvntbaqft (abyegwjinm )
Positive
13 Jun 2026
Phase 3
182
ldzuazbnfg(yqwwllvsct) = wyjmwlpyfl ywywrqdnvv (nfvhaaspud )
Positive
14 Jul 2025
Placebo
ldzuazbnfg(yqwwllvsct) = nogqoxgkmx ywywrqdnvv (nfvhaaspud )
Phase 3
94
kophcjhxbs(ijobxfctbj) = rnezjquibn wktbtnnurq (bvtwjgcodk )
Positive
12 Jul 2025
Placebo
kophcjhxbs(ijobxfctbj) = hpxpiftdqm wktbtnnurq (bvtwjgcodk )
Phase 3
103
vxzotjwrfv(tzmtkhbxta) = kwsuepecih gawgllutpi (meqznqulqk )
Positive
12 Jul 2025
Placebo
vxzotjwrfv(tzmtkhbxta) = fyuolwxjoj gawgllutpi (meqznqulqk )
Phase 3
182
nldfuafdun(fdyanxoevy) = jkzwqipfkh jbaihjvirn (pnrojmzljk )
Positive
12 Jul 2025
Placebo
nldfuafdun(fdyanxoevy) = iafrztrlnx jbaihjvirn (pnrojmzljk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free